Skip to main content
Veterinary Medicines

IDRADE

Authorised
  • Colecalciferol
  • DL-ALPHA TOCOPHEROL ACETATE
  • Retinol

Product identification

Medicine name:
IDRADE
Active substance:
  • Colecalciferol
  • DL-ALPHA TOCOPHEROL ACETATE
  • Retinol
Target species:
  • Cattle
  • Sheep
  • Horse
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Colecalciferol
    75000.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • DL-ALPHA TOCOPHEROL ACETATE
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Retinol
    500000.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Milk
        120
        hour
      • Meat and offal
        287
        day
    • Sheep
      • Milk
        120
        hour
      • Meat and offal
        243
        day
    • Horse
      • Milk
        120
        hour
      • Meat and offal
        287
        day
    • Pig
      • Meat and offal
        259
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA11BA
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Fatro S.p.A.
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 3/06/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."